GlobeNewswire by notified

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

Share

Company announcement – No. 57 / 2022

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

Copenhagen, Denmark and Boston, MA, U.S. December 8, 2022 Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 64,919 divided into 64,919 new shares with a nominal value of DKK 1 each. The increase is a consequence of the exercise of warrants granted under several of Zealand Pharma's employee warrant programs.

Employee warrant programs are part of Zealand Pharma’s incentive scheme, and each warrant gives the owner the right to subscribe for one new Zealand Pharma share at a prespecified price, the exercise price, in specific predefined time periods before expiration. For a more detailed description of Zealand Pharma’s warrant programs, see the company’s Articles of Association, which are available on the website: www.zealandpharma.com.

The exercise price was DKK 100.80 per share for 13,941 of the new shares, DKK 127.00 per share for 40,278 of the new shares and DKK 138.60 per share for 10,700 of the new shares. The total proceeds to Zealand from the capital increase amount to DKK 8,003,579.

The new shares give rights to dividend and other rights from the time of the warrant holder's exercise notice. Each new share carries one vote at Zealand Pharma’s general meetings. Zealand Pharma has only one class of shares.

The new shares will be listed on Nasdaq Copenhagen after registration of the capital increase with the Danish Business Authority. Following registration of the new shares, the share capital of Zealand Pharma will be nominal DKK 51,702,098 divided into 51,702,098 shares with a nominal value of DKK 1 each.

The amendments to Zealand Pharma’s Articles of Association entailed by the share capital increase have been set out below. A full copy of the amended Articles of Association can be found at https://www.zealandpharma.com once registered with the Danish Business Authority.

# # #

About Zealand Pharma A/S

Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development and partnerships with a number of blue-chip pharma companies as well as commercial partnerships for its marketed products.

Zealand was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the U.S. that includes Boston. For more information about Zealand’s business and activities, please visit www.zealandpharma.com.

Forward-Looking Statement

The above information contains forward-looking statements that provide Zealand Pharma’s expectations or forecasts of future events. Such forward-looking statements are subject to risks, uncertainties and inaccurate assumptions, which may cause actual results to differ materially from expectations set forth herein and may cause any or all of such forward-looking statements to be incorrect. If any or all of such forward-looking statements prove to be incorrect, our actual results could differ materially and adversely from those anticipated or implied by such statements. All such forward-looking statements speak only as of the date of this release and are based on information available to Zealand Pharma as of the date of this release. Except as required by law, the Company assumes no obligation to update these forward-looking statements publicly.

Contact:

Anna Krassowska, PhD
Vice President, Investor Relations & Corporate Communications
Zealand Pharma
Email: ank@zealandpharma.com
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Nykredit Bank Group - Annual Report 20228.2.2023 07:30:00 CET | Press release

To Nasdaq Copenhagen A/S and the press8 February 2023 Nykredit today announces the Annual Reports for 2022 of: Nykredit A/S, CVR no 12 71 92 48 Nykredit Realkredit A/S, CVR no 12 71 92 80 Nykredit Bank A/S, CVR no 10 51 96 08 Totalkredit A/S, CVR no 21 83 22 78 Michael Rasmussen, Group Chief Executive, comments on the Annual Report 2022: - Nykredit reported its best ever financial results today. And this is highly satisfactory. 2022 was yet another busy year with high business and customer growth in Nykredit Bank and Totalkredit. We have also recorded growth in Nykredit Wealth Management, which includes Nykredit Invest and Sparinvest. However, given the macroeconomic outlook, we cannot expect the same high activity level and results next year. - 2022 was characterised in particular by the war in Ukraine and its impacts, which quickly fed through to the global economy and fuelled volatility. In times like these, I am particularly proud that customers, colleagues and Nykredit on the whol

Rovio Entertainment Corp.: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act8.2.2023 07:30:00 CET | Press release

Rovio Entertainment Corporation Stock Exchange Release February 8, 2023 at 8.30 a.m. EET Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act Rovio Entertainment Corporation (the "Company") has received a notification pursuant to Chapter 9, Section 5 of the Securities Markets Act from Invesco Ltd. According to the notification, the holding of Invesco Ltd. in the Company's shares and votes decreased below the 5% threshold on February 6, 2023. Following the transaction, Invesco Ltd. owns 2.97% of the Company’s shares and voting rights. Total positions of Invesco Ltd.: % of shares and voting rights% of shares and voting rights through financial instrumentsTotal of both in %Total number of shares and voting rights of issuerResulting situation on the date on which threshold was crossed or reached2.9702.9782,963,825Position of previous notification5.8905.89 Notified details of the resulting situation on the date on which the threshold was crossed or re

Nykredit Realkredit Group - Annual Report 20228.2.2023 07:30:00 CET | Press release

To Nasdaq Copenhagen A/S and the press8 February 2023 Nykredit today announces the Annual Reports for 2022 of: Nykredit A/S, CVR no 12 71 92 48 Nykredit Realkredit A/S, CVR no 12 71 92 80 Nykredit Bank A/S, CVR no 10 51 96 08 Totalkredit A/S, CVR no 21 83 22 78 Michael Rasmussen, Group Chief Executive, comments on the Annual Report 2022: - Nykredit reported its best ever financial results today. And this is highly satisfactory. 2022 was yet another busy year with high business and customer growth in Nykredit Bank and Totalkredit. We have also recorded growth in Nykredit Wealth Management, which includes Nykredit Invest and Sparinvest. However, given the macroeconomic outlook, we cannot expect the same high activity level and results next year. - 2022 was characterised in particular by the war in Ukraine and its impacts, which quickly fed through to the global economy and fuelled volatility. In times like these, I am particularly proud that customers, colleagues and Nykredit on the whol

Sampo plc’s share buybacks 07/02/20238.2.2023 07:30:00 CET | Press release

SAMPO PLC STOCK EXCHANGE RELEASE 08/02/2023 at 08:30 am Sampo plc’s share buybacks 07/02/2023 On 07/02/2023 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows: Sampo plc’s share buybacksAggregated daily volume (in number of shares)Daily weighted average price of the purchased shares*Market (MIC Code)12,66348.11AQEU32,42547.98CEUX14,75548.00TQEX50,15748.06XHELTOTAL110,00048.03 *rounded to two decimals On 9 June 2022, Sampo announced a share buyback programme of up to a maximum of EUR 1 billion in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 10 June 2022, is based on the authorization granted by Sampo's Annual General Meeting on 18 May 2022. After the disclosed transactions, and cancellation of the own shares on 8 December 2022, the company owns in total 5,313,113 Sampo A shares representing 1.03 per cent o

Totalkredit A/S - Årsrapport 20228.2.2023 07:30:00 CET | pressemeddelelse

Til Nasdaq Copenhagen A/S og pressen8. februar 2023 Nykredit offentliggør i dag årsrapporter for 2022 for: Nykredit A/S, CVR-nr. 12 71 92 48 Nykredit Realkredit A/S, CVR-nr. 12 71 92 80 Nykredit Bank A/S, CVR-nr. 10 51 96 08 Totalkredit A/S, CVR-nr. 21 83 22 78 Koncernchef Michael Rasmussen udtaler følgende i forbindelse med årsrapporten: - Vi fremlægger i dag et resultat, der er Nykredits bedste nogensinde. Det er meget tilfredsstillende.2022 blev endnu et år med høj aktivitet, vækst og kundetilgang i både Nykredit Bank og Totalkredit. Vi oplever også fremgang i Nykredit Wealth Management, som favner Nykredit Invest og Sparinvest. På grund af de makroøkonomiske forventninger kan vi dog ikke forvente samme høje aktivitetsniveau og resultat næste år. -2022 har særligt været påvirket af krigen i Ukraine, der hurtigt satte sig spor i den globale økonomiog skabte øget volatilitet. I en tid som denne er jeg særlig stolt af, at både kunder, medarbejdere og Nykredit som helhed har mødt den ak